4650 Sunset Blvd, Ms 108, Los Angeles, CA, 90027 · (323) 669-2164
Beds
386
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$1.43B
FY 2025
Net income
$1.8M
Patient care margin -35.2%
Discharges
18,559
Occupancy 85.2%
Clinicians
71
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.43B | $1.93B | -35.2% | $1.8M | 18,559 | - | 0.3% | - |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5183 Level 3 Vascular Procedures | - | - | - | $2,405.01 |
| APC 5184 Level 4 Vascular Procedures | - | - | - | $3,945.82 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $1.32B | $1.83B | -38.7% | -$42.2M | 18,094 | - | 0.2% | - |
| 2023 | $1.21B | $1.65B | -36.8% | -$81.0M | 17,030 | - | 0.3% | - |
| 2022 | $1.08B | $1.45B | -33.4% | $14.6M | 17,501 | - | 0.4% | - |
| 2021 | $990.4M | $1.33B | -34.7% | $73.2M | 16,296 | - | 0.4% | 59.1% |
| 2020 | $1.07B | $1.33B | -24.4% | -$1.2M | 17,253 | - | 0.5% | 53.2% |
| - |
| - |
| - |
| $1,219.56 |
| APC 5164 Level 4 ENT Procedures | - | - | - | $2,217.17 |
| APC 5192 Level 2 Endovascular Procedures | - | - | - | $4,338.16 |
| APC 5313 Level 3 Lower GI Procedures | - | - | - | $2,176.09 |
| APC 5373 Level 3 Urology and Related Services | - | - | - | $1,516.28 |
| APC 5374 Level 4 Urology and Related Services | - | - | - | $2,629.24 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Mylan Inc. | 2 | $1.2M |
| Ultragenyx Pharmaceutical Inc. RARE | 107 | $602K |
| Janssen Research & Development, LLC JNJ | 21 | $424K |
| Novo Nordisk AS NVO | 38 | $273K |
| Eli Lilly and Company LLY | 7 | $237K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 57 | $229K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $228K |
| Amgen Inc. AMGN | 5 | $203K |
| HEMA Biologics, LLC | 2 | $154K |
| Adaptive Biotechnologies Corporation ADPT | 162 | $152K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Children's Hosp of Los Angeles is a nonprofit children's hospital in Los Angeles, CA with 386 beds, part of Childrens Hospital Los Angeles.
Children's Hosp of Los Angeles in Los Angeles, CA has 386 beds (fiscal year 2025 cost report); 302 beds are certified for Medicare. It discharged 18,559 inpatients that year, with 85.2% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Children's Hosp of Los Angeles reported net patient revenue of $1.43B and operating expenses of $1.93B, a margin on patient care of -35.2%. After other income and expenses its net income was $1.8M (0.1% of revenue), so it made a profit that year.
Children's Hosp of Los Angeles is part of Childrens Hospital Los Angeles, a health system with 1 hospitals based in Los Angeles, CA. It is a nonprofit hospital.
Children's Hosp of Los Angeles has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Children's Hosp of Los Angeles provides emergency services.
71 Medicare clinicians list Children's Hosp of Los Angeles as a hospital they work at, most often in Diagnostic Radiology, Cardiovascular Disease (Cardiology), Pediatric Medicine.
In 2025, companies reported $6.0M in payments to Children's Hosp of Los Angeles as a teaching hospital ($388K general and $5.6M for research) from 66 companies.